KRRO korrobio.com: Bozor kapitallashuvining balans qiymatiga nisbati

Korro Bio, Inc (KRRO) kompaniyasining rasmiy ramzlari

Korro Bio, Inc. (KRRO) OPERA tizimi orqali genomni o'zgartirmasdan, jigar va o'pka patologiyalarini tuzatuvchi RNA korreksiyasi uchun ilg'or muhit yaratmoqda. Biznes patentlar ustidan nazoratni saqlagan holda, birlamchi sinovlar uchun tashqi laboratoriyalarga tayanadi. Bozor qiymatini 1.72 deb ko'rsatuvchi ushbu grafik aktivning salohiyatini tasdiqlaydi. Korro Bio, Inc. (KRRO) favqulodda inqirozga chidamlilikka ega, chunki uning muvaffaqiyati faqat klinik sinovlar bosqichlariga bog'liq.

korrobio.com (KRRO): Kapitallashuvning balans qiymatiga nisbati 21.02.2024dan 27.10.2026gacha

Korro Bio, Inc. (KRRO) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi korrobio.com|KRRO - Oʻrtacha prognoz narxi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Korro Bio, Inc|KRRO - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Korro Bio|KRRO - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati korrobio.com|KRRO - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Korro Bio, Inc.|KRRO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati korrobio.com|KRRO - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Korro Bio, Inc
Fundamental baholash:KRRO (Korro Bio Inc.)
korrobio.com yetakchi tovari

Ushbu koeffitsient biznesning bozor qiymatini uning sof aktivlari bilan solishtirib, fundamental tiklanish davrlarida kapitalning haddan tashqari yuqori yoki past baholanganlik darajasini aniqlaydi. Bozor qiymatining buxgalteriya qiymatiga nisbati grafigini tahlil qilish orqali investor Korro Bio, Inc. (KRRO) kompaniyasining avtonom RNK tahrirlash tadqiqotlariga o'tish samaradorligini baholashi mumkin, chunki kompaniyaning qiymati o'tmishdagi birlashmalardan ko'ra ko'proq klinikadan oldingi ishlanmalarning borishiga bog'lana boshlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor qiymatining balans qiymatiga nisbati TEM|qiagen.com (QGEN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Beam Therapeutics - Bozor qiymatining balans qiymatiga nisbati|SRPT: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati TWST|TXG (10x) - Bozor qiymatining balans qiymatiga koeffitsiyenti|NTLA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati STOK|BioLife Solutions (BLFS) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati WVE (Wave Life Sciences Ltd)|MAZE: Bozor qiymatining balans qiymatiga nisbati|SION - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati Prime Medicine, Inc. (PRME)|TSHA - Balans qiymatiga nisbatan bozor qiymati|uniQure (QURE) - Bozor kapitallashuvining balans qiymatiga nisbati|MeiraGTx Holdings (MGTX) - Bozor qiymatining balans qiymatiga nisbati|RGNX: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SLDB|Ocugen, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti pacb.com PACB|Kapitallashuvning sof aktivlarga nisbati Benitec Biopharma|Balans qiymatiga nisbatan bozor qiymati Design Therapeutics Inc DSGN|Bozor kapitallashuvining balans qiymatiga nisbati RCKT (Rocket Pharmaceuticals Inc)|FDMT: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati lexeotx.com|editasmedicine.com (EDIT) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SLN|Kapitallashuvning sof aktivlarga nisbati ProQR Therapeutics NV (PRQR)|CDXS (Codexis, Inc.) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SGMO (Sangamo BioSciences)|Bozor qiymatining balans qiymatiga nisbati NAUT (Nautilus Bio)|metagenomi.co - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Precision BioSciences (DTIL)|GBIO: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Boundless Bio, Inc BOLD|XCUR (Exicure) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati IMNN (Imunon Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti RXi Pharmaceuticals|Bozor kapitallashuvining balans qiymatiga nisbati Mustang Bio, Inc. MBIO|Kapitallashuvning balans qiymatiga nisbati RNAZ (transcodetherapeutics.com)|BNGO - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Applied DNA Corp APDN|bluebird bio, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|IPA: Bozor kapitallashuvining balans qiymatiga nisbati|OMGA: Bozor qiymatining balans qiymatiga nisbati|OMIC (Singular Genomics Systems, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati RGLS (Regulus Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti SYRS|Telesis Bio, Inc. (TBIO) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati TCON (traconpharma.com)|Bozor qiymatining balans qiymatiga nisbati Unity Biotechnology, Inc.